GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » EV-to-Revenue

Cognetivity Neurosciences (Cognetivity Neurosciences) EV-to-Revenue : 31.36 (As of May. 27, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cognetivity Neurosciences's enterprise value is $2.29 Mil. Cognetivity Neurosciences's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 was $0.07 Mil. Therefore, Cognetivity Neurosciences's EV-to-Revenue for today is 31.36.

The historical rank and industry rank for Cognetivity Neurosciences's EV-to-Revenue or its related term are showing as below:

CGNSF' s EV-to-Revenue Range Over the Past 10 Years
Min: 41.27   Med: 189.71   Max: 649.76
Current: 32.07

During the past 7 years, the highest EV-to-Revenue of Cognetivity Neurosciences was 649.76. The lowest was 41.27. And the median was 189.71.

CGNSF's EV-to-Revenue is ranked worse than
95.78% of 663 companies
in the Healthcare Providers & Services industry
Industry Median: 1.85 vs CGNSF: 32.07

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Cognetivity Neurosciences's stock price is $0.01139. Cognetivity Neurosciences's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was $0.00. Therefore, Cognetivity Neurosciences's PS Ratio for today is .


Cognetivity Neurosciences EV-to-Revenue Historical Data

The historical data trend for Cognetivity Neurosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences EV-to-Revenue Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-Revenue
Get a 7-Day Free Trial - - - - 451.32

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 451.32 616.65 272.40 137.41

Competitive Comparison of Cognetivity Neurosciences's EV-to-Revenue

For the Health Information Services subindustry, Cognetivity Neurosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's EV-to-Revenue falls into.



Cognetivity Neurosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cognetivity Neurosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.289/0.073
=31.36

Cognetivity Neurosciences's current Enterprise Value is $2.29 Mil.
Cognetivity Neurosciences's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cognetivity Neurosciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.01139/0
=

Cognetivity Neurosciences's share price for today is $0.01139.
Cognetivity Neurosciences's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019